ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: CML is a clonal stem cell disease characterized by the proliferation of granulocytes at all stages of differentiation and is driven by the Philadelphia chromosome, which generates an active chimeric BCR-ABL tyrosine kinase [4,6].